Cardiospire
PrivateLast Round
Grant
Oct 1, 2019
Total Funding Raised
$2.43M
Company Overview
Cardiospire operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in October 2019.
Cardiospire is a healthcare and technology company that has developed a non-invasive hemodynamic monitoring device to assess and manage cardiovascular function in ventilated patients.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Telemedicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiospire Comparables
Compare Cardiospire with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bodyport | 84% | |
| Acorai | 82% | |
| Nanowear | 80% |
For institutional investors. Book with your work email.
Cardiospire Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2019 | ||||
| Convertible Debt | Aug 14, 2019 | ||||
| Series A | Mar 1, 2016 |
For institutional investors. Book with your work email.
Cardiospire Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Series A |
| IT-Farm Corporation | Series A |
| MedTech Innovator | Grant |
| Signatures Capital | Series A |
| TheraNova | Series A |
| Synergy Ventures | Series A |
| Johnson & Johnson Innovation - JLABS | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2019
$125K grant received from Johnson & Johnson Innovation - JLABS.
- Aug 14, 2019
$1.3M raised in convertible debt.
For institutional investors. Book with your work email.
Cardiospire Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cardiospire's valuation, stock price, and market status.
Is Cardiospire a public or private company?
Cardiospire is a private company.
What is the current stock price of Cardiospire?
Cardiospire is a private company, so its shares have no public market price. Caplight tracks Cardiospire's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cardiospire worth (valuation)?
Valuation information for Cardiospire is not publicly available.
Can I buy Cardiospire stock?
Cardiospire shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cardiospire's last funding round?
Cardiospire's most recent funding round was Grant on October 1, 2019.
Who are the main investors in Cardiospire?
Key investors in Cardiospire include StartX, IT-Farm Corporation, MedTech Innovator, Signatures Capital, TheraNova.
Will Cardiospire IPO soon?
No public IPO plans have been announced for Cardiospire.
How can I track Cardiospire secondary market activity?
Caplight tracks bids, offers, and trades in Cardiospire's shares on secondary markets.